Morningstar RatingTM:
Series F 4 out of 4 stars (January 31, 2024)
Series D 4 out of 4 stars (January 31, 2024)
Portfolio Management Team:
Date of Inception:
Series F June 15, 2012
Series D June 29, 2012
Fund Size:
$49,846,692 (as of January 31, 2024)
Minimum Purchase:
$500 per account
RRSP/TFSA/RRIF Eligibility:
Yes
Management Fee:
0.70%
Trailer Fee:
    • 0.00% (Series F)
    0.30% (Series D)
Net Asset Value Per Unit:
Series F $24.86  CAD (as of March 4, 2024)
Series D $25.39  CAD (as of March 4, 2024)
Fund Codes:
Series F NGM 270 (CAD)
Series D NGM 272 (CAD)
Available Through an Advisor:
Through registered dealers, FundSERV purchases only.
Investment Growth

Investment Strategy

The objective of the Fund is to achieve long term growth and capital appreciation according to our “Growth at a Reasonable Price” philosophy. The Fund invests in equity securities of Canadian based corporations, avoiding the tobacco and oil and gas industries. On occasion, Treasury bills or short-term cash equivalents may be held.

The Fund’s Simplified Prospectus, Fund Facts and other fund documents can be viewed by visiting the Advisor Fund Documents Page.


Performance

Annualized Trailing Returns

  1 Year 3 Years 5 Years Since Inception
Canadian Equity Fund Series F $CAD -4.8% 3.5% 12.0% 11.4%
Canadian Equity Fund Series D $CAD -5.0% 3.2% 11.7% 10.8%
Benchmark $CAD 4.6% 9.9% 9.6% 8.6%

Calendar Year Returns

  2023 2022 2021 2020 2019
Canadian Equity Fund Series F $CAD 2.5% -7.0% 20.1% 20.9% 37.9%
Canadian Equity Fund Series D $CAD 2.2% -7.3% 19.8% 20.5% 37.5%
Benchmark $CAD 11.8% -5.8% 25.1% 5.6% 22.9%
The Fund’s detailed performance record can be viewed by visiting the Returns Page and the Charts Page.

Fund Holdings and Equity Sector Weights

North Growth Canadian Equity Fund - Top Holdings

Portfolio Date: January 31, 2024

  Ticker Portfolio Weight
TFI International TFII 7.59%
Leon's Furniture LNF 6.72%
ATS Corporation ATS 6.65%
Calian Group CGY 5.97%
Bombardier Cl B BBD.B 5.19%
Open Text Corp. OTEX 4.94%
CAE Inc. CAE 4.80%
Heroux-Devtek HRX 4.59%
Aritzia Inc ATZ 3.89%
Knight Therapeutics GUD 3.49%
Source: North Growth Management

North Growth Canadian Equity Fund - Sectors

As of January 31, 2024


Tax Information

The Fund’s realized income and capital gains are accumulated throughout the year and distributed on a pro rata basis in December. All the distribution details for tax purposes are printed on T-3 slips, and unitholders of the Fund receive their T-3 tax slips by mail near the end of January of the following year.

Distribution History

  Capital Gain,Expressed in Canadian Dollars Capital Gain, As a Percentage of Unit Price
Year Date Series F Series D Series F Series D
2021 December 15 1.52 1.50 5.28% 5.17%
2020 December 15 1.89 1.77 7.20% 6.69%
2019 December 13 0.51 0.32 2.32% 0.28%
2018 December 14 0.69 0.59 3.98% 3.39%
2017 December 15 1.54 1.47 6.86% 6.52%
2016 December 15 1.22 1.08 6.75% 5.98%
2015 December 15 - - - -
2014 December 15 1.52 1.33 7.46% 6.54%
2013 December 15 1.03 0.95 5.34% 4.95%

Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Please read the prospectus before investing. The indicated rates of return are the historical annual compounded total returns including changes in unit value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any unitholder that would have reduced returns. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated. North Growth Canadian Equity Fund benchmark = S&P/TSX Composite Index.

The Morningstar Rating reflects how the Fund has performed on a risk-adjusted basis relative to the other funds in the Morningstar Canadian Small/Mid Cap Equity category, and is subject to change every month. Funds are ranked by their Morningstar Risk-Adjusted Return scores with the top 10% of funds in a category receiving 5 stars, the next 22.5% receiving 4 stars, a fund in the middle 35% receiving 3 stars, a fund in the next 22.5% receiving 2 stars and a fund in the bottom 10% receiving 1 star. The Fund received a 5 star rating for the 3 year time period ending January 31, 2024 among 204 funds in the category and a 5 star rating for the 5 year time period ending January 31, 2024 among 188 funds in the category and the 10 year time period among 143 funds in the category. The weighted average of these time-period ratings provide the Overall Morningstar Rating for the Fund shown above. For further details see www.morningstar.ca.